Three anesthesia drugs all have the same effect in the brain, MIT researchers find March 19, 2026 Discovering this common mechanism could lead to a universal anesthesia-delivery system to monitor patients more effectively. Chakraborty, Collins receive prestigious international prize March 19, 2026 The two IMES faculty members have been honored for their long, distinguished careers in physical science. Biswas Fellows advance early-stage ideas at the frontiers of health and life sciences March 18, 2026 Five early-career researchers have been named Biswas Fellows, joining a growing cohort supported by the MIT Health and Life Sciences Collaborative (HEALS) to pursue bold, interdisciplinary research with the potential to improve human health. Can AI help predict which heart-failure patients will worsen within a year? March 17, 2026 Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance. 3 Questions: Building predictive models to characterize tumor progression March 17, 2026 Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment. Injectable “satellite livers” could offer an alternative to liver transplantation March 6, 2026 The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure. MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators March 4, 2026 Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation. IMES community profile: Thomas Fryer February 25, 2026 Thomas Fryer, an IMES-based PostDoc, has a wide variety of research interests, including designing snake antivenom and novel antimicrobials. Using synthetic biology and AI to address global antimicrobial resistance threat February 13, 2026 Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed. AI algorithm enables tracking of vital white matter pathways February 13, 2026 Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next Last page Last » Side navigation News Events
Three anesthesia drugs all have the same effect in the brain, MIT researchers find March 19, 2026 Discovering this common mechanism could lead to a universal anesthesia-delivery system to monitor patients more effectively.
Chakraborty, Collins receive prestigious international prize March 19, 2026 The two IMES faculty members have been honored for their long, distinguished careers in physical science.
Biswas Fellows advance early-stage ideas at the frontiers of health and life sciences March 18, 2026 Five early-career researchers have been named Biswas Fellows, joining a growing cohort supported by the MIT Health and Life Sciences Collaborative (HEALS) to pursue bold, interdisciplinary research with the potential to improve human health.
Can AI help predict which heart-failure patients will worsen within a year? March 17, 2026 Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
3 Questions: Building predictive models to characterize tumor progression March 17, 2026 Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Injectable “satellite livers” could offer an alternative to liver transplantation March 6, 2026 The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators March 4, 2026 Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
IMES community profile: Thomas Fryer February 25, 2026 Thomas Fryer, an IMES-based PostDoc, has a wide variety of research interests, including designing snake antivenom and novel antimicrobials.
Using synthetic biology and AI to address global antimicrobial resistance threat February 13, 2026 Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.
AI algorithm enables tracking of vital white matter pathways February 13, 2026 Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.
